Skip to main navigation

1.866.648.2767

info@tabularasahealthcare.com

Investors
mobilemenu

Investors - Investor News

Investors - Investor News

Keyword Search

Year

Tabula Rasa HealthCare Reports First Quarter 2022 Results

05 May 2022

Tabula Rasa HealthCare Schedules First Quarter 2022 Earnings Conference Call

21 Apr 2022

Tabula Rasa HealthCare Announces Partnership Extension with Gary and Mary West PACE

29 Mar 2022

New Study Further Validates Cost Savings from Unique Medication Risk Mitigation Technology

17 Mar 2022

Tabula Rasa HealthCare Reports Fourth Quarter and Full Year 2021 Results

24 Feb 2022

HopeWest to Employ Full Line of TRHC's CareVention HealthCare Offerings to Support PACE Startup

14 Feb 2022

Tabula Rasa HealthCare Schedules Fourth Quarter 2021 Earnings Conference Call

10 Feb 2022

Tabula Rasa Healthcare to Sell DoseMeRx

09 Feb 2022

Tabula Rasa HealthCare and Evernorth Extend Agreement Expanding Medication Safety, Efficacy, and Adherence Services

04 Jan 2022

New Studies Shed Light on Opioid-Related Drug Interactions

09 Dec 2021

Pagination

First page
Previous page
Page 1
Page 2
Page 3
Current page 4
Page 5
Page 6
Page 7
Page 8
Page 9
…
Next page
Last page

Investor Relations

Overview
Investor News
Events & Presentations
Stock Information
Corporate Governance
Financial Information
Investor Resources

IR CONTACT

Frank Sparacino

(866) 648-2767

fsparacino@trhc.com

RECEIVE E-MAIL ALERTS

Stay up to date on the latest Tabula Rasa HealthCare (TRHC) news.

Contact Us

1.866.648.2767

info@tabularasahealthcare.com

228 Strawbridge Drive
Moorestown NJ 08057

Careers

We are looking for individuals that can grow with our company. We offer a comprehensive benefits package, along with competitive compensation. Learn more today by clicking below.

Learn more >

©2023 Tabula Rasa Healthcare Legal | Privacy | Contact Us